参考文献

参考文献

［1］Blute M L，Leibovich B C，Lohse C M，et al.The Mayo Clinic experience with surgical management，complications and outcome for patients with renal cell carcinoma and venous tumour thrombus［J］.BJU Int，2004，94（1）：33-41.

［2］Colin P，Koenig P，Ouzzane A，et al.Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract［J］.BJU Int，2009，104（10）：1436-1340.

［3］Cowan N C，Turney B M，Taylor N J，et al.Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour［J］.BJU Int，2007.99（6）：1363-1670.

［4］Giannarini G，Thomas M K，Frederic D B，et al.Antegrade perfusion with bacillus Calmette-Guerin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract：who may benefit［J］.Eur Urol，2011，60（5）：955-960.

［5］Inman B A，Tran V T，Fradet Y，et al.Carcinoma of the upper urinary tract：predictors of survival and competing causes of mortality［J］.Cancer，2009，115（13）：2853-2862.

［6］Jeldres C，Lughezzani G，Sun M，et al.Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter［J］.J Urol，2010，183（4）：1324-1329.

［7］Ouzzane A，Colin P，Xylinas E，et al.Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy［J］.Eur Urol，2011，60（6）：1258-1265.(https://www.daowen.com)

［8］Rojas C P，Castle S M，Llanos C A，et al.Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma［J］.Urologic oncology，2013，31（8）：1696-1700.

［9］Roscigno M，Cha E K，Rink M，et al.International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis［J］.BJU Int，2012.110（5）：674-681.

［10］Seisen T，Peyronnet B，Dominguez J L，et al.Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma：a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel［J］.Eur Urol，2016，70（6）：1052-1068.

［11］Siegel R L，Miller K D，Fuchs H E，et al.Cancer Statistics，2021［J］.CA Cancer J Clin，2021，71（1）：7-33.

［12］Takahashi N，Glockner J F，Hartman R P，et al.Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy［J］.J Urol，2010，183（4）：1330-1365.

［13］Tomisaki I，Kubo T，Minato A，et al.Efficacy and tolerability of bacillus calmetteguerin therapy as the first-line therapy for upper urinary tract carcinoma in situ［J］.Cancer Invest，2018，36（2）：1-6.

［14］Villa L，Cloutier J，Letendre J，et al.Early repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma：preliminary findings［J］.World J Urol，2016.34（9）：1201-1206.